B-Cell-Related Neuroinflammation Across Central Nervous System Diseases: A Bibliometric and Science-Mapping Analysis, 2006–2026
Journal of Inflammation Research · 2026-10 · Volume 19 · 1-23
DOI: 10.2147/jir.s635719 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Inflammation Research, 2026-10. Verfasst von Juan Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Xiangya School of Basic Medical Sciences, Central South University, Changsha, Hunan, 410013, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Purpose
Research on B cells in central nervous system (CNS) diseases rests on a mature multiple sclerosis (MS) literature, whereas evidence in CNS injury and neurodegeneration is still emerging. We mapped publications from 2006 to 2026 and separated bibliometric visibility from mechanistic maturity.
Methods
We searched the Web of Science Core Collection (WoSCC) on August 17, 2026, for English-language records carrying the Article document-type tag and published from January 1, 2006, through August 17, 2026. Two reviewers independently screened all records, with unresolved disagreements adjudicated by a third reviewer. Publication trends, collaboration, co-citation, journal flows, citation bursts, and keyword evolution were analyzed using VOSviewer, CiteSpace, bibliometrix, R, and SCImago Graphica. Search materials, parameters, and source tables were archived.
Results
After database-level limits, 2,701 records were screened; 467 (17.3%) were excluded and 2,234 (82.7%) included. The corpus had accrued 91,218 WoSCC citations. Annual output rose from 91 articles in 2016 to 231 in 2025; 173 articles from 2026 represent a partial year. The United States contributed the most articles, and the University of California, San Francisco ranked first after affiliation normalization. Co-citation and keyword analyses showed an MS/experimental autoimmune encephalomyelitis (EAE)-centered foundation built around B-cell depletion trials, meningeal pathology, diagnostic criteria, and regulatory B-cell biology. Recent bursts included anti-CD20 therapy, single-cell RNA sequencing, autoimmune encephalitis, ischemic stroke, Mendelian randomization, B-cell depletion, and Alzheimer disease.
Conclusion
B-cell-related CNS research has expanded, but evidence maturity remains disease-specific. MS/EAE provides the clearest foundation. Findings in CNS injury, neurodegeneration, and candidate peripheral-CNS routes remain context-dependent and require validation by disease, anatomical compartment, B-cell state, and stage. Bibliometric prominence reveals attention, not shared causality or therapeutic efficacy. B cells are well established as important contributors to multiple sclerosis, but their roles in other brain and spinal cord disorders are less clear. We examined 2,234 research articles published between 2006 and August 2026 to see how the field developed, who worked together, which papers shaped it, and which topics are gaining attention. The literature remains centered on multiple sclerosis and its experimental models, especially studies of B-cell-depleting treatments and B-cell accumulation around the meninges. Research is expanding into autoimmune encephalitis, stroke, neurodegeneration, and communication between peripheral organs and the central nervous system, but much of this work is still disease-specific or based on animal models. We therefore separated highly visible topics from mechanisms supported by stronger human evidence. We also archived the search strategy, screening codebook, scripts, and source data so the analysis can be checked. The main message is that B cells should not be treated as one uniform target across all central nervous system diseases: the relevant B-cell state, location, disease stage, and biological function need to be defined before findings can guide treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physiology, Xiangya School of Basic Medical Sciences, Central South University, Changsha, Hunan, 410013, People's Republic of China.
- Key Laboratory of General University of Hunan Province, Basic and Clinical Research in Major Respiratory Disease, Central South University, Changsha, Hunan, 410013, People's Republic of China.
- National Experimental Teaching Demonstration Center for Medical Function, Central South University, Changsha, Hunan, 410013, People's Republic of China.
Zitieren
APA
Li, J., Wang, W. J., Chen, H., Sun, J. Q., Zhong, W. J., Guan, C. X., & Zhou, Y. (2026). B-Cell-Related Neuroinflammation Across Central Nervous System Diseases: A Bibliometric and Science-Mapping Analysis, 2006–2026. Journal of Inflammation Research, Volume 19, 1-23. https://doi.org/10.2147/jir.s635719
Vancouver
Li J, Wang WJ, Chen H, Sun JQ, Zhong WJ, Guan CX, et al. B-Cell-Related Neuroinflammation Across Central Nervous System Diseases: A Bibliometric and Science-Mapping Analysis, 2006–2026. Journal of Inflammation Research. 2026;Volume 19:1-23. doi:10.2147/jir.s635719
BibTeX
@article{Li2026,
author = {Li, Juan and Wang, Wen-Jia and Chen, Hui and Sun, Jia-Qi and Zhong, Wen-Jing and Guan, Cha-Xiang and Zhou, Yong},
title = {B-Cell-Related Neuroinflammation Across Central Nervous System Diseases: A Bibliometric and Science-Mapping Analysis, 2006–2026},
journal = {Journal of Inflammation Research},
year = {2026},
volume = {Volume 19},
pages = {1--23},
doi = {10.2147/jir.s635719}
}
EUVIMED